Among the most prominent molecular drivers of glioma-associated inflammation is tumor necrosis factor-alpha (TNF-α) [3], a pleiotropic cytokine that modulates various cellular processes, including proliferation, survival, differentiation, and immune responses. This evidence concerns the gene TNF and central nervous system cancer.